A detailed history of Mariner, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Mariner, LLC holds 16,546 shares of PRCT stock, worth $491,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,546
Previous 15,295 8.18%
Holding current value
$491,250
Previous $880,000 32.95%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$35.69 - $60.06 $44,648 - $75,135
1,251 Added 8.18%
16,546 $590,000
Q2 2025

Aug 14, 2025

BUY
$48.82 - $65.05 $123,953 - $165,161
2,539 Added 19.9%
15,295 $880,000
Q1 2025

May 15, 2025

BUY
$56.03 - $88.57 $243,730 - $385,279
4,350 Added 51.75%
12,756 $743,000
Q4 2024

Feb 13, 2025

BUY
$67.27 - $99.45 $163,398 - $241,564
2,429 Added 40.64%
8,406 $676,000
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $336,564 - $507,985
5,977 New
5,977 $478,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $1.32B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.